Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Pediatr Pulmonol ; 59(1): 121-128, 2024 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-37818776

RESUMO

OBJECTIVES: Guidelines for asthma management recommend, before establishing additional therapeutic behaviors, to confirm correct use and adequate therapeutic adherence to treatment. Evidence exists on the use of fractional exhaled nitric oxide (FeNO) values for monitoring therapeutic adherence in adults. It is important to establish whether there is a correlation between FeNO and therapeutic adherence in children. This study aims to provide new knowledge about the relationship between FeNO and therapeutic adherence in asthmatic children. MATERIALS AND METHODS: Analytical cross-sectional study including asthma patients 5-18 years of age, attending follow-up at Hospital Militar Central (HMC) between May and November 2022 in Colombia. A sociodemographic survey was carried out, followed by the Pediatric Inhaler Adherence Questionnaire (PIAQ), and asthma control test (ACT) or childhood asthma control test (cACT). We defined adequate therapeutic adherence as not missing a single application of inhaled steroids in the last 15 days according to PIAQ. A poisson regression model was carried out including relevant predictors for therapeutic adherence such as FeNO values, age, tobacco exposure at home, atopy, and time since initiation of use of inhaled controller. RESULTS: Eighty-two children with a median age of 10 years (interquartile range: 7-12 years) were included. Adequate therapeutic adherence was reported by 68.3%. After adjusting for age, sex, exposure to cigarette smoke, duration of controller therapy, and atopy, FeNO < 20 ppb was independently associated with adequate therapeutic adherence (RR = 1.5, p = .04, 95% confidence interval: 1.03-2.19). CONCLUSIONS: FeNO values seem to be useful to identify pediatric patients with asthma who have adequate adherence to inhaled steroids in a MIC.


Assuntos
Asma , Hipersensibilidade Imediata , Adulto , Humanos , Criança , Teste da Fração de Óxido Nítrico Exalado , Estudos Transversais , Óxido Nítrico/uso terapêutico , Testes Respiratórios , Asma/tratamento farmacológico , Esteroides/uso terapêutico , Expiração
2.
J Asthma ; 58(11): 1488-1494, 2021 11.
Artigo em Inglês | MEDLINE | ID: mdl-32715830

RESUMO

OBJECTIVE: Although the assessment of a bronchodilator response (BDR) is a routine and important procedure when performing lung function tests, comparisons between spirometric and oscillometric BDRs in asthmatic children living at high altitude have not been previously reported. The aim of the present study was to compare spirometric and oscillometric BDRs in children living at high altitude, and to identify independent predictors of spirometric and oscillometric BDRs. METHODS: Between January and December, 2015, asthmatic children aged between 5 and 17 years old performed impulse oscillometry (IOS) and spirometry during the same visit before and after albuterol administration. The data were analyzed, and children were classified into those positive for oscillometric BDR only, those positive for spirometric BDR only, those positive for both BDRs, and those negative for both BDRs. RESULTS: Ninety-three asthmatic children (56 boys, 37 girls), with a median (IQR) age of 11 (8-13) years, made up the study population. Among the total of 93 participants, 13 (14.0%), 4 (4.3%), 0 (0%), and 76 (81.7%) were positive for spirometric BDR only, positive for oscillometric BDR only, positive for both BDRs, and negative for both BDRs, respectively. Age and baseline lung function were identified as significant predictors of positive spirometric BDR. CONCLUSIONS: The present study shows poor concordance between positive spirometric and oscillometric BDRs, with a greater proportion of patients with a spirometric BDR when compared to those with positive oscillometric BDR. Additionally, age and baseline lung function are useful for predicting spirometric BDR results.


Assuntos
Albuterol/uso terapêutico , Altitude , Asma/tratamento farmacológico , Asma/fisiopatologia , Broncodilatadores/uso terapêutico , Oscilometria , Espirometria , Adolescente , Criança , Feminino , Humanos , Masculino , Resultado do Tratamento
3.
Clin Respir J ; 14(11): 1011-1017, 2020 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-32692908

RESUMO

OBJECTIVES: This study was aimed to provide locally derived spirometric equations from a population of healthy children residing in Bogota, Colombia, a high-altitude city. METHODS: Healthy children aged more than 6 years up to less than 18 years underwent spirometry from January 2017 to January 2018, following the recommendations made by the American Thoracic Society/European Respiratory Society (ATS/ERS) Task Force. We performed stepwise multiple regression analyses to predict each spirometric parameter. We also performed extensive residual analyses comparing the measured values with those calculated with our new spirometric equations and with other commonly used equations. RESULTS: Predictive equations for each spirometric variable were derived from 326 spirometric tests (149 boys, 177 girls). Our newly derived spirometric equations provided the minimum of median of prediction error for almost all spirometric indices measured. CONCLUSION: We recommend the newly developed spirometric equations for assessing the ventilatory function of children living in Bogota, Colombia.


Assuntos
Altitude , Criança , Feminino , Volume Expiratório Forçado , Humanos , Masculino , Valores de Referência , Análise de Regressão , Espirometria , Capacidade Vital
4.
Pediatr Pulmonol ; 54(6): 886-893, 2019 06.
Artigo em Inglês | MEDLINE | ID: mdl-30957980

RESUMO

OBJECTIVES: To identify the spirometric equations that are most appropriate for use in children and adolescents living in Bogota, Colombia after evaluating a set of relevant previously-developed equations, including the Global Lung Function Initiative (GLI) 2012 spirometry reference equations. METHODS: Healthy children aged between 6 and 17 years that were attending two randomly-selected schools in Bogota were invited to participate in the study, from January 2017 to January 2018. All participants underwent spirometry, following the procedures recommended by the American Thoracic Society/European Respiratory Society (ATS/ERS) Task Force. To identify the model or group of models that best predict each spirometric parameter in our population, we performed extensive residuals analyses and constructed Bland-Altman plots. RESULTS: Three hundred twenty-six spirometric tests (149 boys, 177 girls) formed the reference data set. Knudson and GLI-2012 spirometry reference equations proved to be the most accurate in predicting the majority of spirometry parameters in both sexes and both age groups, each providing the lowest median prediction error in the residual analyses or the narrowest limits of agreement in the Bland-Altman plots in approximately one-third of the spirometry parameters analyzed. CONCLUSION: For the majority of spirometry parameters, we recommend the use of Knudson and GLI-2012 spirometry reference equations for evaluating the respiratory function of children living in Bogota, Colombia, a city located at an altitude of 2640 m. Future investigations should target additional spirometric equations from Latin American populations living at moderate to high altitude to improve the GLI-2012 equations.


Assuntos
Altitude , Volume Expiratório Forçado , Fluxo Máximo Médio Expiratório , Espirometria/métodos , Espirometria/normas , Capacidade Vital , Adolescente , Antropometria , Criança , Cidades , Colômbia , Feminino , Humanos , Masculino , Valores de Referência , Reprodutibilidade dos Testes , Instituições Acadêmicas , Estudantes , Inquéritos e Questionários , População Urbana , População Branca
5.
Artif Cells Nanomed Biotechnol ; 46(sup2): 766-775, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29961338

RESUMO

Second generation E. coli DH5α (pKAU17) was successfully encapsulated by means of atomization (MA), inkjet printing (MI) and double-encapsulation (DDMI) for the purpose of urea degradation in a simulated uremic medium at 37 °C. Experimentally determined values of the effectiveness factor are 0.83, 0.28 and 0.34 for the MI, MA and DDMI capsules, respectively, suggesting that the catalytic activity of the E. coli DH5α (pKAU17) immobilized in MI capsule (d = 52 µm ± 2.7 µm) is significantly less diffusion-limited than in the case of the MA (d = 1558 µm ± 125 µm) and DDMI (d = 1370 µm ± 60 µm) bio-encapsulation schemes at the 98.3% CI. The proposed novel double encapsulation biofabrication method for alginate-based microspheres, characterized by lower membrane degradation rates due to secondary containment is recommended compared to the standard atomization scheme currently adopted across immobilization-based therapeutic scenarios. A Fickian-based mechanism is proposed with simulations mimicking urea degradation for a single capsule for the atomization and the inkjet schemes.


Assuntos
Células Artificiais/microbiologia , Escherichia coli/metabolismo , Miniaturização , Ureia/metabolismo , Difusão , Cinética
6.
Cytometry B Clin Cytom ; 94(1): 172-181, 2018 01.
Artigo em Inglês | MEDLINE | ID: mdl-28316130

RESUMO

BACKGROUND: The aim of this work was to simultaneously use multiplex ligation-dependent probe amplification (MLPA) assay and flow cytometric DNA ploidy analysis (FPA) to detect aneuploidy in patients with newly diagnosed acute leukemia. METHODS: MLPA assay and propidium iodide FPA were used to test samples from 53 consecutive patients with newly diagnosed acute leukemia referred to our laboratory for immunophenotyping. Results were compared by nonparametric statistics. RESULTS: The combined use of both methods significantly increased the rate of detection of aneuploidy as compared to that obtained by each method alone. The limitations of one method are somehow countervailed by the other and vice versa. CONCLUSIONS: MPLA and FPA yield different yet complementary information concerning aneuploidy in acute leukemia. The simultaneous use of both methods might be recommended in the clinical setting. © 2017 International Clinical Cytometry Society.


Assuntos
DNA/genética , Leucemia Mieloide Aguda/genética , Aneuploidia , Feminino , Citometria de Fluxo/métodos , Humanos , Imunofenotipagem/métodos , Masculino , Reação em Cadeia da Polimerase Multiplex/métodos , Ploidias
7.
Rev. med. vet. (Bogota) ; (26): 101-113, jul.-dic. 2013. ilus
Artigo em Espanhol | LILACS-Express | LILACS | ID: lil-696645

RESUMO

La enfermedad de Schmallenberg (SBV) es una enfermedad viral emergente producida por un Orthobunyavirus que fue detectado por primera vez en bovinos a finales del 2011 en Alemania. Este afectaba de igual forma a ovinos y caprinos, y particularmente en estas especies generaba malformaciones congénitas en fetos de hembras preñadas, al igual que fiebre y baja en la producción de leche. Hoy en día, esta enfermedad ya se encuentra distribuida en varios países de Europa, y se sabe que en su transmisión están implicados vectores culicoides y mosquitos que, para las especies afectadas, desempeñan un papel importante en su epidemiología. Por otra parte, se ha establecido que la SBV no se puede considerar una zoonosis, ya que hasta el momento no hay suficientes evidencias científicas que demuestren lo contrario.


Schmallenberg (SBV) is an emerging viral disease caused by an Orthobunyavirus that was first detected in cattle at the end of 2011 in Germany. If similarly affected sheep and goats, which particularly generated congenital malformations in fetuses of pregnant females of these species, as well as fever and low milk production. Nowadays, this disease is already distributed in several European countries, and it is known that culicoides vectors and mosquitoes-which play an important role in the epidemiology for the affected species- are involved in the transmission of the disease. On the other hand, it has been established that SBV cannot be considered a zoonosis, seeing as so far there is not enough scientific evidence to prove otherwise.


A doença de Schmallenberg (SBV) é uma doença viral emergente produzida por um Orthobunyavirus que foi detectado por primeira vez em bovinos a finais de 2011 em Alemanha. Este afetava de igual forma a ovinos e caprinos, o que gerava particularmente nestas espécies malformações congênitas em fetos de fêmeas prenhas, igualmente que febre e baixa na produção de leite. Hoje em dia, esta doença já se encontra distribuída em vários países de Europa, e se sabe que na transmissão da doença estão implicados vetores culicoides e mosquitos que, para as espécies afetadas, desempenham um papel importante em sua epidemiologia. Por outra parte, foi estabelecido que a SBV não pode ser considerada uma zoonose, já que até o momento não há suficientes evidências científicas que demonstrem o contrário.

8.
Hematology ; 17 Suppl 1: S63-5, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22507782

RESUMO

Flow cytometric analysis of cell suspensions involves the sequential 'registration' of intrinsic and extrinsic parameters of thousands of cells in list mode files. Thus, it is almost irresistible to describe phenomena in numerical terms or by 'ratios' that have the appearance of 'accuracy' due to the presence of numbers obtained from thousands of cells. The concepts involved in the detection and characterization of B cell lymphoproliferative processes are revisited in this paper by identifying parameters that, when analyzed appropriately, are both necessary and sufficient. The neoplastic process (cluster) can be visualized easily because the parameters that distinguish it form a cluster in multidimensional space that is unique and distinguishable from neighboring clusters that are not of diagnostic interest but serve to provide a background. For B cell neoplasia it is operationally necessary to identify the multidimensional space occupied by a cluster whose kappa:lambda ratio is 100:0 or 0:100. Thus, the concept of kappa:lambda ratio is without meaning and would not detect B cell neoplasia in an unacceptably high number of cases.


Assuntos
Linfócitos B/imunologia , Citometria de Fluxo/métodos , Transtornos Linfoproliferativos/diagnóstico , Transtornos Linfoproliferativos/imunologia , Análise por Conglomerados , Humanos , Cadeias kappa de Imunoglobulina/análise , Cadeias kappa de Imunoglobulina/imunologia , Cadeias lambda de Imunoglobulina/análise , Cadeias lambda de Imunoglobulina/imunologia , Neoplasia Residual/diagnóstico , Neoplasia Residual/imunologia
9.
Cytometry B Clin Cytom ; 70(1): 39-44, 2006 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-16353215

RESUMO

On May 3 and 4, 2005, the Second Latin American Consensus Conference for the Immunophenotyping of Hematological Malignancies took place in Queretaro, México, with representatives from 10 countries of the region and two external consultants. This document summarizes the major conclusions for which consensus were achieved. Major differences regarding the recommendations from the first conference, which took place 9 years ago, concern the medical indications and the antibody panels for immunophenotyping. The aim of disseminating these guidelines to the international community is based on the potential interest for other countries with similar socioeconomic conditions.


Assuntos
Citometria de Fluxo/métodos , Neoplasias Hematológicas/metabolismo , Imunofenotipagem/métodos , Anticorpos Monoclonais/imunologia , Coleta de Dados , Corantes Fluorescentes/análise , Neoplasias Hematológicas/imunologia
10.
Rev. invest. clín ; 49(4): 317-22, jul.-ago. 1997. tab
Artigo em Espanhol | LILACS | ID: lil-219683

RESUMO

El día 16 de octubre de 1996 se llevó a cabo, en la ciudad de Puebla, México, la primera Conferencia Latinoamericana de Consenso para la Tipificación Inmunológica de Leucemia. En dicha conferencia estuvieron representados 10 países de la región y hubo dos asesores externos: las principales conclusiones a las que se llegaron por acuerdo de los presentes se resumen en esta publicación


Assuntos
Humanos , Anticorpos Monoclonais , Imunofenotipagem/instrumentação , Imunofenotipagem/métodos , Imunofenotipagem , Leucemia/classificação , Leucemia/diagnóstico , Transtornos Linfoproliferativos/diagnóstico , Transtornos Mieloproliferativos/diagnóstico , Prognóstico
11.
Bogota, D.C; s.n; jul. 1993. 54 p. tab, graf.
Tese em Espanhol | LILACS | ID: lil-190128

RESUMO

Se evaluó la secuencia gasimétrica por gases capilares arterializados (BCA) saturación por oximetría transcutánea (St02) y la evolución clínica de pacientes que requirieron hospitalización por Infección Respiratoria Aguda de Vías aéreas bajas (IRAB) de probable etiología viral. Se incluyó los pacientes hospitalizados por IRAB de posible etiología viral en el período de Marzo de 1992 a Mayo de 1993. Debido a que no se contó con cultivos ni métodos serológicos para detección de Virus, el diagnóstico se hizo mediante la clínica (episodio de menos de 15 días con tos, ruidos bronquiales audibles a distancia, dificultad respiratoria, fiebre, signología bronco-obstructiva (SBO) o sin ella, sin signos de consolidación y que no necesitaran antibióticos) asociado a ninguno o máximo uno de los reactantes de fase aguda (leucocitos mayor a 20.000 x mm3, PMN mayor a 30 mm y PCR mayor a 64 mg/L). Al ingreso se tomó CH, VSG, PCR, Rx de Tórax, GCA y St02 con Fi02 al 0.21. Se dió de alta cuando la clínica mostraba mejoría y la St02 era mayor o igual a 85 por ciento. Se excluyó a todo paciente con antecedente de enfermedad respiratoria en el período neonatal, patología respiratoria crónica, malformaciones congénitas o episodios sibilantes previos. Se hizo seguimiento clínico, GCA y St02 mensualmente después de su egreso hasta obtener dos St02 consecutivos normales (mayor o igual a 88 por ciento) a Fi02 0.21. De 60 pacientes seleccionados sólo 30 asistieron a los controles post-hospitalización


Assuntos
Criança , Lactente , Infecções Respiratórias
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...